TAMARA BENNETT-NOLLEY: Open Payments
NPI 1598061301 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,009 in 124 payments from 24 companies in 2025. Trend: 2023 $1,772 · 2024 $1,994 · 2025 $3,009
Food & beverage: $3,009
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $929 |
| Dendreon Pharmaceuticals LLC | 11 | $294 |
| Sumitomo Pharma America, Inc. | 15 | $285 |
| PFIZER INC. | 10 | $252 |
| Merck Sharp & Dohme LLC | 8 | $194 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $160 |
| UROGEN PHARMA, INC. | 6 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Olympus America Inc. | 4 | $95 |
| IMMUNITYBIO, INC. | 2 | $76 |
Products named: ERLEADA, PROVENGE, XTANDI, GEMTESA, Nubeqa, LYNPARZA, PLUVICTO, iTIND System.
Industry payments across OK — which companies pay providers there.
